nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—CYP2C8—Pazopanib—kidney cancer	0.123	0.339	CbGbCtD
Tazarotene—CYP2C8—Erlotinib—kidney cancer	0.0876	0.242	CbGbCtD
Tazarotene—CYP2C8—Paclitaxel—kidney cancer	0.0801	0.222	CbGbCtD
Tazarotene—CYP2C8—Sorafenib—kidney cancer	0.0712	0.197	CbGbCtD
Tazarotene—Localised oedema—Pazopanib—kidney cancer	0.0212	0.0452	CcSEcCtD
Tazarotene—Facial pain—Capecitabine—kidney cancer	0.0134	0.0286	CcSEcCtD
Tazarotene—Leukoderma—Pazopanib—kidney cancer	0.0126	0.0269	CcSEcCtD
Tazarotene—Pain of skin—Paclitaxel—kidney cancer	0.01	0.0215	CcSEcCtD
Tazarotene—Cheilitis—Everolimus—kidney cancer	0.00992	0.0212	CcSEcCtD
Tazarotene—Hypertriglyceridaemia—Temsirolimus—kidney cancer	0.00987	0.0211	CcSEcCtD
Tazarotene—Localised oedema—Paclitaxel—kidney cancer	0.00937	0.02	CcSEcCtD
Tazarotene—Blood triglycerides increased—Temsirolimus—kidney cancer	0.00866	0.0185	CcSEcCtD
Tazarotene—Leukoderma—Sunitinib—kidney cancer	0.00829	0.0177	CcSEcCtD
Tazarotene—Cheilitis—Sunitinib—kidney cancer	0.00829	0.0177	CcSEcCtD
Tazarotene—Cheilitis—Dactinomycin—kidney cancer	0.00785	0.0168	CcSEcCtD
Tazarotene—Localised oedema—Capecitabine—kidney cancer	0.00769	0.0164	CcSEcCtD
Tazarotene—Hypertriglyceridaemia—Everolimus—kidney cancer	0.00735	0.0157	CcSEcCtD
Tazarotene—Localized exfoliation—Capecitabine—kidney cancer	0.00721	0.0154	CcSEcCtD
Tazarotene—RARG—Vitamin A and Carotenoid Metabolism—ALDH1A1—kidney cancer	0.00704	0.0413	CbGpPWpGaD
Tazarotene—Skin hyperpigmentation—Erlotinib—kidney cancer	0.00684	0.0146	CcSEcCtD
Tazarotene—Acne—Temsirolimus—kidney cancer	0.00674	0.0144	CcSEcCtD
Tazarotene—Blood triglycerides increased—Everolimus—kidney cancer	0.00644	0.0138	CcSEcCtD
Tazarotene—RARB—Vitamin A and Carotenoid Metabolism—ALDH1A1—kidney cancer	0.00632	0.037	CbGpPWpGaD
Tazarotene—RARA—Vitamin A and Carotenoid Metabolism—ALDH1A1—kidney cancer	0.00606	0.0355	CbGpPWpGaD
Tazarotene—RXRB—Vitamin A and Carotenoid Metabolism—ALDH1A1—kidney cancer	0.00606	0.0355	CbGpPWpGaD
Tazarotene—Skin hyperpigmentation—Sunitinib—kidney cancer	0.00592	0.0127	CcSEcCtD
Tazarotene—Skin discolouration—Pazopanib—kidney cancer	0.00592	0.0127	CcSEcCtD
Tazarotene—Blister—Erlotinib—kidney cancer	0.00565	0.0121	CcSEcCtD
Tazarotene—Skin exfoliation—Pazopanib—kidney cancer	0.0051	0.0109	CcSEcCtD
Tazarotene—Acne—Everolimus—kidney cancer	0.00501	0.0107	CcSEcCtD
Tazarotene—Blister—Sunitinib—kidney cancer	0.00489	0.0105	CcSEcCtD
Tazarotene—RARG—Vitamin A and Carotenoid Metabolism—CRABP1—kidney cancer	0.00488	0.0286	CbGpPWpGaD
Tazarotene—Acne—Erlotinib—kidney cancer	0.00484	0.0103	CcSEcCtD
Tazarotene—Swelling—Temsirolimus—kidney cancer	0.00467	0.00998	CcSEcCtD
Tazarotene—Eczema—Temsirolimus—kidney cancer	0.00458	0.0098	CcSEcCtD
Tazarotene—RARB—Vitamin A and Carotenoid Metabolism—CRABP1—kidney cancer	0.00438	0.0257	CbGpPWpGaD
Tazarotene—Inflammation—Everolimus—kidney cancer	0.00435	0.0093	CcSEcCtD
Tazarotene—Dermatitis bullous—Temsirolimus—kidney cancer	0.00431	0.00921	CcSEcCtD
Tazarotene—RARA—Vitamin A and Carotenoid Metabolism—CRABP1—kidney cancer	0.0042	0.0246	CbGpPWpGaD
Tazarotene—RXRB—Vitamin A and Carotenoid Metabolism—CRABP1—kidney cancer	0.0042	0.0246	CbGpPWpGaD
Tazarotene—Inflammation—Erlotinib—kidney cancer	0.0042	0.00897	CcSEcCtD
Tazarotene—Acne—Sunitinib—kidney cancer	0.00419	0.00896	CcSEcCtD
Tazarotene—Skin exfoliation—Everolimus—kidney cancer	0.00403	0.00861	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Paclitaxel—kidney cancer	0.00398	0.00851	CcSEcCtD
Tazarotene—RARG—Vitamin A and Carotenoid Metabolism—SCARB1—kidney cancer	0.00392	0.023	CbGpPWpGaD
Tazarotene—Skin discolouration—Sunitinib—kidney cancer	0.0039	0.00834	CcSEcCtD
Tazarotene—Skin exfoliation—Erlotinib—kidney cancer	0.00389	0.00831	CcSEcCtD
Tazarotene—Dry skin—Temsirolimus—kidney cancer	0.00377	0.00807	CcSEcCtD
Tazarotene—Dry skin—Pazopanib—kidney cancer	0.00355	0.0076	CcSEcCtD
Tazarotene—RARB—Vitamin A and Carotenoid Metabolism—SCARB1—kidney cancer	0.00351	0.0206	CbGpPWpGaD
Tazarotene—Sensitisation—Doxorubicin—kidney cancer	0.00351	0.0075	CcSEcCtD
Tazarotene—Skin exfoliation—Sorafenib—kidney cancer	0.0035	0.00748	CcSEcCtD
Tazarotene—Hypertriglyceridaemia—Capecitabine—kidney cancer	0.00338	0.00723	CcSEcCtD
Tazarotene—RARA—Vitamin A and Carotenoid Metabolism—SCARB1—kidney cancer	0.00337	0.0197	CbGpPWpGaD
Tazarotene—RXRB—Vitamin A and Carotenoid Metabolism—SCARB1—kidney cancer	0.00337	0.0197	CbGpPWpGaD
Tazarotene—Skin exfoliation—Sunitinib—kidney cancer	0.00336	0.00719	CcSEcCtD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.00328	0.0192	CbGpPWpGaD
Tazarotene—Skin hyperpigmentation—Capecitabine—kidney cancer	0.00327	0.00698	CcSEcCtD
Tazarotene—Dermatitis bullous—Erlotinib—kidney cancer	0.00309	0.00661	CcSEcCtD
Tazarotene—Photosensitivity reaction—Pazopanib—kidney cancer	0.00306	0.00654	CcSEcCtD
Tazarotene—Blood triglycerides increased—Capecitabine—kidney cancer	0.00296	0.00634	CcSEcCtD
Tazarotene—Eczema—Sorafenib—kidney cancer	0.00296	0.00633	CcSEcCtD
Tazarotene—Leukoderma—Doxorubicin—kidney cancer	0.00295	0.0063	CcSEcCtD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.00294	0.0172	CbGpPWpGaD
Tazarotene—Eczema—Sunitinib—kidney cancer	0.00285	0.00609	CcSEcCtD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.00282	0.0165	CbGpPWpGaD
Tazarotene—Dry skin—Everolimus—kidney cancer	0.00281	0.006	CcSEcCtD
Tazarotene—Oedema peripheral—Temsirolimus—kidney cancer	0.00281	0.006	CcSEcCtD
Tazarotene—Dry skin—Erlotinib—kidney cancer	0.00271	0.00579	CcSEcCtD
Tazarotene—Skin exfoliation—Gemcitabine—kidney cancer	0.0027	0.00577	CcSEcCtD
Tazarotene—Haemoglobin—Pazopanib—kidney cancer	0.0027	0.00577	CcSEcCtD
Tazarotene—Blister—Capecitabine—kidney cancer	0.0027	0.00576	CcSEcCtD
Tazarotene—Haemorrhage—Pazopanib—kidney cancer	0.00268	0.00574	CcSEcCtD
Tazarotene—Dermatitis bullous—Sunitinib—kidney cancer	0.00268	0.00572	CcSEcCtD
Tazarotene—Oedema peripheral—Pazopanib—kidney cancer	0.00264	0.00565	CcSEcCtD
Tazarotene—Skin discolouration—Paclitaxel—kidney cancer	0.00262	0.0056	CcSEcCtD
Tazarotene—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—kidney cancer	0.00252	0.0148	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—EPAS1—kidney cancer	0.0025	0.0146	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—HNF1A—kidney cancer	0.0025	0.0146	CbGpPWpGaD
Tazarotene—Erythema—Temsirolimus—kidney cancer	0.00248	0.0053	CcSEcCtD
Tazarotene—Dry skin—Sorafenib—kidney cancer	0.00244	0.00521	CcSEcCtD
Tazarotene—Dry skin—Sunitinib—kidney cancer	0.00234	0.00501	CcSEcCtD
Tazarotene—Erythema—Pazopanib—kidney cancer	0.00234	0.00499	CcSEcCtD
Tazarotene—RXRB—Regulation of Androgen receptor activity—EGR1—kidney cancer	0.00232	0.0136	CbGpPWpGaD
Tazarotene—Skin exfoliation—Paclitaxel—kidney cancer	0.00226	0.00483	CcSEcCtD
Tazarotene—Skin discolouration—Capecitabine—kidney cancer	0.00215	0.0046	CcSEcCtD
Tazarotene—Dermatitis bullous—Gemcitabine—kidney cancer	0.00215	0.00459	CcSEcCtD
Tazarotene—Haemoglobin—Vinblastine—kidney cancer	0.00214	0.00457	CcSEcCtD
Tazarotene—Haemoglobin—Everolimus—kidney cancer	0.00213	0.00455	CcSEcCtD
Tazarotene—Haemorrhage—Vinblastine—kidney cancer	0.00213	0.00455	CcSEcCtD
Tazarotene—Haemorrhage—Everolimus—kidney cancer	0.00212	0.00453	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Doxorubicin—kidney cancer	0.00211	0.0045	CcSEcCtD
Tazarotene—Oedema peripheral—Everolimus—kidney cancer	0.00209	0.00446	CcSEcCtD
Tazarotene—Haemoglobin—Erlotinib—kidney cancer	0.00205	0.00439	CcSEcCtD
Tazarotene—Haemorrhage—Erlotinib—kidney cancer	0.00204	0.00437	CcSEcCtD
Tazarotene—Oedema—Temsirolimus—kidney cancer	0.00202	0.00433	CcSEcCtD
Tazarotene—Inflammation—Capecitabine—kidney cancer	0.002	0.00428	CcSEcCtD
Tazarotene—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—kidney cancer	0.00197	0.0116	CbGpPWpGaD
Tazarotene—Swelling—Paclitaxel—kidney cancer	0.00195	0.00417	CcSEcCtD
Tazarotene—Oedema—Pazopanib—kidney cancer	0.00191	0.00408	CcSEcCtD
Tazarotene—Skin exfoliation—Capecitabine—kidney cancer	0.00185	0.00397	CcSEcCtD
Tazarotene—Haemoglobin—Sorafenib—kidney cancer	0.00185	0.00395	CcSEcCtD
Tazarotene—Erythema—Everolimus—kidney cancer	0.00184	0.00394	CcSEcCtD
Tazarotene—Haemorrhage—Sorafenib—kidney cancer	0.00184	0.00393	CcSEcCtD
Tazarotene—Burning sensation—Doxorubicin—kidney cancer	0.0018	0.00385	CcSEcCtD
Tazarotene—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—kidney cancer	0.0018	0.0105	CbGpPWpGaD
Tazarotene—Erythema—Erlotinib—kidney cancer	0.00178	0.00381	CcSEcCtD
Tazarotene—Haemoglobin—Sunitinib—kidney cancer	0.00178	0.0038	CcSEcCtD
Tazarotene—Haemorrhage—Sunitinib—kidney cancer	0.00177	0.00378	CcSEcCtD
Tazarotene—Oedema peripheral—Sunitinib—kidney cancer	0.00174	0.00373	CcSEcCtD
Tazarotene—Blister—Doxorubicin—kidney cancer	0.00174	0.00372	CcSEcCtD
Tazarotene—Pain—Temsirolimus—kidney cancer	0.00173	0.0037	CcSEcCtD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—MET—kidney cancer	0.00172	0.0101	CbGpPWpGaD
Tazarotene—Photosensitivity reaction—Vincristine—kidney cancer	0.00171	0.00365	CcSEcCtD
Tazarotene—Pain—Pazopanib—kidney cancer	0.00163	0.00349	CcSEcCtD
Tazarotene—Erythema—Sorafenib—kidney cancer	0.0016	0.00342	CcSEcCtD
Tazarotene—Swelling—Capecitabine—kidney cancer	0.0016	0.00342	CcSEcCtD
Tazarotene—Dry skin—Paclitaxel—kidney cancer	0.00158	0.00337	CcSEcCtD
Tazarotene—Discomfort—Vinblastine—kidney cancer	0.00156	0.00333	CcSEcCtD
Tazarotene—Discomfort—Everolimus—kidney cancer	0.00155	0.00332	CcSEcCtD
Tazarotene—Stinging—Doxorubicin—kidney cancer	0.00155	0.00331	CcSEcCtD
Tazarotene—Erythema—Sunitinib—kidney cancer	0.00154	0.00329	CcSEcCtD
Tazarotene—Oedema—Everolimus—kidney cancer	0.00151	0.00322	CcSEcCtD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—CDH1—kidney cancer	0.00149	0.00875	CbGpPWpGaD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—MAPK3—kidney cancer	0.00148	0.00865	CbGpPWpGaD
Tazarotene—Dermatitis bullous—Capecitabine—kidney cancer	0.00148	0.00316	CcSEcCtD
Tazarotene—Erythema—Dactinomycin—kidney cancer	0.00146	0.00312	CcSEcCtD
Tazarotene—Oedema—Erlotinib—kidney cancer	0.00145	0.00311	CcSEcCtD
Tazarotene—Pruritus—Temsirolimus—kidney cancer	0.00143	0.00306	CcSEcCtD
Tazarotene—Haemoglobin—Gemcitabine—kidney cancer	0.00143	0.00305	CcSEcCtD
Tazarotene—Haemorrhage—Gemcitabine—kidney cancer	0.00142	0.00304	CcSEcCtD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—MAPK1—kidney cancer	0.00141	0.00823	CbGpPWpGaD
Tazarotene—Oedema peripheral—Gemcitabine—kidney cancer	0.0014	0.00299	CcSEcCtD
Tazarotene—Skin discolouration—Doxorubicin—kidney cancer	0.00139	0.00296	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.00137	0.008	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.00137	0.008	CbGpPWpGaD
Tazarotene—Photosensitivity reaction—Paclitaxel—kidney cancer	0.00136	0.0029	CcSEcCtD
Tazarotene—Pruritus—Pazopanib—kidney cancer	0.00135	0.00288	CcSEcCtD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—MAPK3—kidney cancer	0.00132	0.00776	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.00131	0.00767	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.00131	0.00767	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.00129	0.00758	CbGpPWpGaD
Tazarotene—Dry skin—Capecitabine—kidney cancer	0.00129	0.00276	CcSEcCtD
Tazarotene—Pain—Vinblastine—kidney cancer	0.00129	0.00276	CcSEcCtD
Tazarotene—Inflammation—Doxorubicin—kidney cancer	0.00129	0.00276	CcSEcCtD
Tazarotene—Pain—Everolimus—kidney cancer	0.00129	0.00275	CcSEcCtD
Tazarotene—Rash—Temsirolimus—kidney cancer	0.00128	0.00273	CcSEcCtD
Tazarotene—Dermatitis—Temsirolimus—kidney cancer	0.00127	0.00273	CcSEcCtD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—MAPK3—kidney cancer	0.00127	0.00744	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—MAPK3—kidney cancer	0.00127	0.00744	CbGpPWpGaD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—MAPK1—kidney cancer	0.00126	0.00738	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—ERBB2—kidney cancer	0.00126	0.00738	CbGpPWpGaD
Tazarotene—Oedema—Sunitinib—kidney cancer	0.00126	0.00269	CcSEcCtD
Tazarotene—Pain—Erlotinib—kidney cancer	0.00124	0.00266	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.00124	0.00727	CbGpPWpGaD
Tazarotene—Dermatitis contact—Doxorubicin—kidney cancer	0.00124	0.00265	CcSEcCtD
Tazarotene—Erythema—Gemcitabine—kidney cancer	0.00124	0.00264	CcSEcCtD
Tazarotene—Discomfort—Dactinomycin—kidney cancer	0.00123	0.00262	CcSEcCtD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—MAPK1—kidney cancer	0.00121	0.00708	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—MAPK1—kidney cancer	0.00121	0.00708	CbGpPWpGaD
Tazarotene—Rash—Pazopanib—kidney cancer	0.0012	0.00257	CcSEcCtD
Tazarotene—Dermatitis—Pazopanib—kidney cancer	0.0012	0.00257	CcSEcCtD
Tazarotene—Skin exfoliation—Doxorubicin—kidney cancer	0.0012	0.00256	CcSEcCtD
Tazarotene—Haemoglobin—Paclitaxel—kidney cancer	0.00119	0.00256	CcSEcCtD
Tazarotene—Oedema—Dactinomycin—kidney cancer	0.00119	0.00255	CcSEcCtD
Tazarotene—Haemorrhage—Paclitaxel—kidney cancer	0.00119	0.00254	CcSEcCtD
Tazarotene—Oedema peripheral—Paclitaxel—kidney cancer	0.00117	0.0025	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.00113	0.0066	CbGpPWpGaD
Tazarotene—Pain—Sorafenib—kidney cancer	0.00112	0.00239	CcSEcCtD
Tazarotene—Photosensitivity reaction—Capecitabine—kidney cancer	0.00111	0.00238	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.00108	0.00632	CbGpPWpGaD
Tazarotene—Pain—Sunitinib—kidney cancer	0.00108	0.0023	CcSEcCtD
Tazarotene—Pruritus—Everolimus—kidney cancer	0.00106	0.00228	CcSEcCtD
Tazarotene—Oedema—Vincristine—kidney cancer	0.00106	0.00227	CcSEcCtD
Tazarotene—RARG—Vitamin A and Carotenoid Metabolism—MAPK1—kidney cancer	0.00105	0.00617	CbGpPWpGaD
Tazarotene—Discomfort—Gemcitabine—kidney cancer	0.00104	0.00222	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.00103	0.00606	CbGpPWpGaD
Tazarotene—Erythema—Paclitaxel—kidney cancer	0.00103	0.00221	CcSEcCtD
Tazarotene—Pruritus—Erlotinib—kidney cancer	0.00103	0.0022	CcSEcCtD
Tazarotene—Pain—Dactinomycin—kidney cancer	0.00102	0.00218	CcSEcCtD
Tazarotene—Eczema—Doxorubicin—kidney cancer	0.00101	0.00216	CcSEcCtD
Tazarotene—Oedema—Gemcitabine—kidney cancer	0.00101	0.00216	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000992	0.00581	CbGpPWpGaD
Tazarotene—Haemoglobin—Capecitabine—kidney cancer	0.00098	0.0021	CcSEcCtD
Tazarotene—Haemorrhage—Capecitabine—kidney cancer	0.000976	0.00209	CcSEcCtD
Tazarotene—RXRB—Regulation of Androgen receptor activity—JUN—kidney cancer	0.000975	0.00571	CbGpPWpGaD
Tazarotene—Oedema peripheral—Capecitabine—kidney cancer	0.000961	0.00206	CcSEcCtD
Tazarotene—Dermatitis bullous—Doxorubicin—kidney cancer	0.000951	0.00203	CcSEcCtD
Tazarotene—Rash—Everolimus—kidney cancer	0.000949	0.00203	CcSEcCtD
Tazarotene—Dermatitis—Everolimus—kidney cancer	0.000948	0.00203	CcSEcCtD
Tazarotene—CYP2C8—Xenobiotics—CYP1A1—kidney cancer	0.000948	0.00555	CbGpPWpGaD
Tazarotene—RARB—Vitamin A and Carotenoid Metabolism—MAPK1—kidney cancer	0.000945	0.00554	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—HARS—kidney cancer	0.000933	0.00546	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000929	0.00544	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000929	0.00544	CbGpPWpGaD
Tazarotene—Pruritus—Sorafenib—kidney cancer	0.000924	0.00198	CcSEcCtD
Tazarotene—Rash—Erlotinib—kidney cancer	0.000916	0.00196	CcSEcCtD
Tazarotene—Dermatitis—Erlotinib—kidney cancer	0.000915	0.00196	CcSEcCtD
Tazarotene—CYP2C8—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000912	0.00534	CbGpPWpGaD
Tazarotene—Pain—Vincristine—kidney cancer	0.000909	0.00194	CcSEcCtD
Tazarotene—RARA—Vitamin A and Carotenoid Metabolism—MAPK1—kidney cancer	0.000906	0.00531	CbGpPWpGaD
Tazarotene—RXRB—Vitamin A and Carotenoid Metabolism—MAPK1—kidney cancer	0.000906	0.00531	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000899	0.00527	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000891	0.00522	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000891	0.00522	CbGpPWpGaD
Tazarotene—Pruritus—Sunitinib—kidney cancer	0.000889	0.0019	CcSEcCtD
Tazarotene—CYP2C8—Biological oxidations—ACY1—kidney cancer	0.000872	0.00511	CbGpPWpGaD
Tazarotene—Discomfort—Paclitaxel—kidney cancer	0.00087	0.00186	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000869	0.00509	CbGpPWpGaD
Tazarotene—Pain—Gemcitabine—kidney cancer	0.000863	0.00184	CcSEcCtD
Tazarotene—Erythema—Capecitabine—kidney cancer	0.000849	0.00182	CcSEcCtD
Tazarotene—Oedema—Paclitaxel—kidney cancer	0.000845	0.00181	CcSEcCtD
Tazarotene—RARB—Gene Expression—HARS—kidney cancer	0.000837	0.0049	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000833	0.00488	CbGpPWpGaD
Tazarotene—Dry skin—Doxorubicin—kidney cancer	0.000833	0.00178	CcSEcCtD
Tazarotene—Rash—Sorafenib—kidney cancer	0.000824	0.00176	CcSEcCtD
Tazarotene—Dermatitis—Sorafenib—kidney cancer	0.000823	0.00176	CcSEcCtD
Tazarotene—RXRB—Gene Expression—HARS—kidney cancer	0.000802	0.0047	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HARS—kidney cancer	0.000802	0.0047	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—EIF5B—kidney cancer	0.000793	0.00465	CbGpPWpGaD
Tazarotene—Rash—Sunitinib—kidney cancer	0.000793	0.0017	CcSEcCtD
Tazarotene—Dermatitis—Sunitinib—kidney cancer	0.000792	0.00169	CcSEcCtD
Tazarotene—RARA—Adipogenesis—HIF1A—kidney cancer	0.000789	0.00462	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000763	0.00447	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—PIK3CA—kidney cancer	0.000758	0.00444	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000756	0.00443	CbGpPWpGaD
Tazarotene—Rash—Dactinomycin—kidney cancer	0.00075	0.0016	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000739	0.00433	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000732	0.00428	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000725	0.00425	CbGpPWpGaD
Tazarotene—Pain—Paclitaxel—kidney cancer	0.000722	0.00154	CcSEcCtD
Tazarotene—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000717	0.00153	CcSEcCtD
Tazarotene—Discomfort—Capecitabine—kidney cancer	0.000714	0.00153	CcSEcCtD
Tazarotene—Pruritus—Gemcitabine—kidney cancer	0.000714	0.00153	CcSEcCtD
Tazarotene—RARB—Gene Expression—EIF5B—kidney cancer	0.000711	0.00417	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000708	0.00415	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS1—kidney cancer	0.000707	0.00414	CbGpPWpGaD
Tazarotene—Oedema—Capecitabine—kidney cancer	0.000693	0.00148	CcSEcCtD
Tazarotene—RARA—Gene Expression—EIF5B—kidney cancer	0.000682	0.00399	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—EIF5B—kidney cancer	0.000682	0.00399	CbGpPWpGaD
Tazarotene—Rash—Vincristine—kidney cancer	0.00067	0.00143	CcSEcCtD
Tazarotene—Dermatitis—Vincristine—kidney cancer	0.00067	0.00143	CcSEcCtD
Tazarotene—Rash—Gemcitabine—kidney cancer	0.000636	0.00136	CcSEcCtD
Tazarotene—Dermatitis—Gemcitabine—kidney cancer	0.000635	0.00136	CcSEcCtD
Tazarotene—Haemoglobin—Doxorubicin—kidney cancer	0.000632	0.00135	CcSEcCtD
Tazarotene—Haemorrhage—Doxorubicin—kidney cancer	0.000629	0.00134	CcSEcCtD
Tazarotene—Oedema peripheral—Doxorubicin—kidney cancer	0.000619	0.00132	CcSEcCtD
Tazarotene—Pruritus—Paclitaxel—kidney cancer	0.000598	0.00128	CcSEcCtD
Tazarotene—Pain—Capecitabine—kidney cancer	0.000593	0.00127	CcSEcCtD
Tazarotene—Erythema—Doxorubicin—kidney cancer	0.000547	0.00117	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000533	0.00312	CbGpPWpGaD
Tazarotene—Rash—Paclitaxel—kidney cancer	0.000532	0.00114	CcSEcCtD
Tazarotene—Dermatitis—Paclitaxel—kidney cancer	0.000532	0.00114	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—JUNB—kidney cancer	0.000515	0.00301	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—EEF2—kidney cancer	0.000511	0.00299	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000511	0.00299	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000495	0.0029	CbGpPWpGaD
Tazarotene—Pruritus—Capecitabine—kidney cancer	0.00049	0.00105	CcSEcCtD
Tazarotene—RARG—Gene Expression—TET2—kidney cancer	0.00049	0.00287	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—ALDH1A1—kidney cancer	0.000478	0.0028	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—CTNNB1—kidney cancer	0.000472	0.00276	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—JUNB—kidney cancer	0.000462	0.0027	CbGpPWpGaD
Tazarotene—Discomfort—Doxorubicin—kidney cancer	0.00046	0.000985	CcSEcCtD
Tazarotene—RARB—Gene Expression—EEF2—kidney cancer	0.000458	0.00268	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000455	0.00267	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—TCEB1—kidney cancer	0.000448	0.00262	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—TCEB2—kidney cancer	0.000448	0.00262	CbGpPWpGaD
Tazarotene—Oedema—Doxorubicin—kidney cancer	0.000447	0.000955	CcSEcCtD
Tazarotene—RXRB—Generic Transcription Pathway—JUNB—kidney cancer	0.000442	0.00259	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—JUNB—kidney cancer	0.000442	0.00259	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—TET2—kidney cancer	0.000439	0.00257	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—EEF2—kidney cancer	0.000439	0.00257	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—EEF2—kidney cancer	0.000439	0.00257	CbGpPWpGaD
Tazarotene—Rash—Capecitabine—kidney cancer	0.000437	0.000935	CcSEcCtD
Tazarotene—Dermatitis—Capecitabine—kidney cancer	0.000437	0.000934	CcSEcCtD
Tazarotene—RARA—Gene Expression—TET2—kidney cancer	0.000421	0.00247	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—TET2—kidney cancer	0.000421	0.00247	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000419	0.00245	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000418	0.00245	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000414	0.00242	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000404	0.00237	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—TCEB2—kidney cancer	0.000402	0.00235	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—TCEB1—kidney cancer	0.000402	0.00235	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000401	0.00235	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000397	0.00232	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000394	0.00231	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000388	0.00228	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000388	0.00227	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—TCEB1—kidney cancer	0.000385	0.00226	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—TCEB2—kidney cancer	0.000385	0.00226	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—TCEB2—kidney cancer	0.000385	0.00226	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—TCEB1—kidney cancer	0.000385	0.00226	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000383	0.00224	CbGpPWpGaD
Tazarotene—Pain—Doxorubicin—kidney cancer	0.000382	0.000817	CcSEcCtD
Tazarotene—RARB—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000376	0.0022	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000367	0.00215	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000365	0.00214	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000365	0.00214	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—RPL14—kidney cancer	0.000364	0.00213	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000362	0.00212	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—CDKN2B—kidney cancer	0.00036	0.00211	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—CDKN2B—kidney cancer	0.00036	0.00211	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000353	0.00207	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.00035	0.00205	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.00035	0.00205	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000347	0.00203	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000338	0.00198	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—RPL14—kidney cancer	0.000327	0.00191	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000319	0.00187	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000319	0.00187	CbGpPWpGaD
Tazarotene—Pruritus—Doxorubicin—kidney cancer	0.000316	0.000676	CcSEcCtD
Tazarotene—RARA—Gene Expression—RPL14—kidney cancer	0.000313	0.00183	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—RPL14—kidney cancer	0.000313	0.00183	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000305	0.00179	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.000301	0.00177	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—EIF4EBP1—kidney cancer	0.000297	0.00174	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—HSPB1—kidney cancer	0.000297	0.00174	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000293	0.00172	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.000293	0.00172	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.000289	0.00169	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.000287	0.00168	CbGpPWpGaD
Tazarotene—Rash—Doxorubicin—kidney cancer	0.000282	0.000602	CcSEcCtD
Tazarotene—Dermatitis—Doxorubicin—kidney cancer	0.000281	0.000602	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.000281	0.00165	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTT1—kidney cancer	0.000281	0.00164	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PSMD7—kidney cancer	0.000276	0.00162	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.000275	0.00161	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000271	0.00159	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.000271	0.00159	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—EIF4EBP1—kidney cancer	0.000266	0.00156	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HSPB1—kidney cancer	0.000266	0.00156	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—PTGS1—kidney cancer	0.000263	0.00154	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.00026	0.00152	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HSPB1—kidney cancer	0.000255	0.0015	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—EIF4EBP1—kidney cancer	0.000255	0.0015	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—EIF4EBP1—kidney cancer	0.000255	0.0015	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HSPB1—kidney cancer	0.000255	0.0015	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	0.000249	0.00146	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—JUNB—kidney cancer	0.000248	0.00145	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PSMD7—kidney cancer	0.000248	0.00145	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	0.000241	0.00141	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	0.000239	0.0014	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000238	0.00139	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PSMD7—kidney cancer	0.000237	0.00139	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PSMD7—kidney cancer	0.000237	0.00139	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000232	0.00136	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	0.000231	0.00135	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—JUNB—kidney cancer	0.000222	0.0013	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—JUNB—kidney cancer	0.000213	0.00125	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—JUNB—kidney cancer	0.000213	0.00125	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—CDKN2B—kidney cancer	0.000202	0.00118	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTP1—kidney cancer	0.000195	0.00114	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTP1—kidney cancer	0.000192	0.00112	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—CDKN2B—kidney cancer	0.000181	0.00106	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTM1—kidney cancer	0.000179	0.00105	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTM1—kidney cancer	0.000176	0.00103	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—CDKN2B—kidney cancer	0.000173	0.00102	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—CDKN2B—kidney cancer	0.000173	0.00102	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP1A1—kidney cancer	0.000169	0.000993	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP1A1—kidney cancer	0.000167	0.000979	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—MYC—kidney cancer	0.000162	0.000951	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ACY1—kidney cancer	0.000149	0.000873	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—MYC—kidney cancer	0.000146	0.000853	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—MYC—kidney cancer	0.00014	0.000818	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—MYC—kidney cancer	0.00014	0.000818	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000127	0.000745	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PDHB—kidney cancer	0.000127	0.000743	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—POMC—kidney cancer	0.000126	0.00074	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CCBL1—kidney cancer	0.000119	0.000698	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000108	0.000631	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GLIPR1—kidney cancer	0.000103	0.000605	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPAT—kidney cancer	0.000103	0.000605	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000102	0.000598	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000101	0.000592	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—FH—kidney cancer	9.61e-05	0.000563	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APRT—kidney cancer	9.61e-05	0.000563	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	9.39e-05	0.00055	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GPC3—kidney cancer	9.03e-05	0.000529	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CA2—kidney cancer	8.79e-05	0.000515	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALAD—kidney cancer	8.56e-05	0.000502	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ST3GAL2—kidney cancer	8.36e-05	0.00049	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALDH1A1—kidney cancer	8.17e-05	0.000479	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MAPK3—kidney cancer	8.04e-05	0.000471	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC5A3—kidney cancer	7.83e-05	0.000459	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PGK1—kidney cancer	7.83e-05	0.000459	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MYC—kidney cancer	7.82e-05	0.000458	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LDHB—kidney cancer	7.68e-05	0.00045	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MAPK3—kidney cancer	7.21e-05	0.000422	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MYC—kidney cancer	7.01e-05	0.000411	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MAPK3—kidney cancer	6.91e-05	0.000405	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MAPK3—kidney cancer	6.91e-05	0.000405	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MYC—kidney cancer	6.72e-05	0.000394	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MYC—kidney cancer	6.72e-05	0.000394	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CA9—kidney cancer	6.66e-05	0.00039	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.51e-05	0.000381	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CRABP1—kidney cancer	5.66e-05	0.000332	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ITPR2—kidney cancer	5.26e-05	0.000308	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.85e-05	0.000284	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ACHE—kidney cancer	4.8e-05	0.000281	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTT1—kidney cancer	4.8e-05	0.000281	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SCARB1—kidney cancer	4.54e-05	0.000266	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS1—kidney cancer	4.5e-05	0.000263	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PSMD7—kidney cancer	4.41e-05	0.000258	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—BCHE—kidney cancer	4.18e-05	0.000245	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC5A5—kidney cancer	4.13e-05	0.000242	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC2A1—kidney cancer	3.99e-05	0.000234	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.87e-05	0.000227	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.38e-05	0.000198	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTP1—kidney cancer	3.33e-05	0.000195	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCB1—kidney cancer	3.15e-05	0.000184	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTM1—kidney cancer	3.06e-05	0.000179	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP1A1—kidney cancer	2.9e-05	0.00017	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.38e-05	0.000139	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—POMC—kidney cancer	2.16e-05	0.000127	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS2—kidney cancer	1.72e-05	0.000101	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTEN—kidney cancer	1.5e-05	8.81e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.06e-05	6.21e-05	CbGpPWpGaD
